| 英文别名 |
A 366;A-366;5′-Methoxy-6′-[3-(1-pyrrolidinyl)propoxy]-spiro[cyclobutane-1,3′-[3H]indol]-2′-amine;5'-Methoxy-6'-[3-(1-pyrrolidinyl)propoxy]spiro[cyclobutane-1,3'-[3H]indol]-2'-amine;5'-methoxy-6'-[3-(pyrrolidin-1-yl)propoxy]spiro[cyclobutane-1,3'-indole]-2'-amine;5'-methoxy-6'-(3-(pyrrolidin-1-yl)propoxy)spiro[cyclobutane-1,3'-indol]-2'-amine;5'-Methoxy-6'-[3-(Pyrrolidin-1-Yl)propoxy]spiro[cyclobutane-1,3'-Indol]-2'-Amine;A366;GTPL8238;BKCDJTRMYWSXMC-UHFFFAOYSA-N;BCP17827;BDBM50446376;s7572;SB1;CID 76285486;CS-2077; A366;A-336;Spiro[cyclobutane-1,3'-[3H]indol]-2'-amine, 5'-methoxy-6'-[3-(1-pyrrolidinyl)propoxy]-;11,selective,cells,peptide-competitive,epigenetics,Inhibitor,interaction,inhibit,H3K4me3,Epigenetic Reader Domain,leukemia,Histone Methyltransferase,methyltransferase;5'-methoxy-6'-(3-(pyrrolidin-1-yl)propoxy)spiro(cyclobutane-1,3'-indole)-2'-amine;CCG-267804;A-366?;AC-36029;C72892;CLC50311;SB19047;A-366, >=98% (HPLC);BRD-K06182768-001-03-1;BRD-K06182768-001-02-3;SCHEMBL17106564;5'-methoxy-6'-(3-pyrrolidin-1-ylpropoxy)spiro[cyclobutane-1,3'-indole]-2'-amine;5'-Methoxy-6'-[3-(1-pyrrolidinyl)propoxy]-spiro[cyclobutane-1,3'-[3H]indol]-2'-amine,;DA-70411;5'-methoxy-6'-[3-(pyrrolidin-1-yl)propoxy]-1'H-spiro[cyclobutane-1,3'-indol]-2'-imine;BS-15549;CHEMBL3109630;CS-4644;BRD-K06182768-001-01-5;HY-12583;1527503-11-2;Q27074068;AKOS024458525;EX-A2328;NCGC00351478-04 |
微信公众号
客服
